Introduction Semaglutide has emerged as a revolutionary medication in the realm of healthcare, targeting conditions like obesity, type 2 diabetes, and cardiovascular risks. Part of the GLP-1 receptor agonists family, Semaglutide mimics the hormone glucagon-like peptide-1 (GLP-1), which plays a pivotal role in regulating blood sugar, stimulating insulin release, and https://dna-test-in-delhi08530.wikidank.com/1077450/semaglutide_a_breakthrough_in_managing_type_2_diabetes_obesity_and_heart_health